| Literature DB >> 33880548 |
Maureen M Black1,2, Sylvia Fernandez-Rao3, Krishnapillai Madhavan Nair4, Nagalla Balakrishna5, Nicholas Tilton6, Kankipati Vijaya Radhakrishna7, Punjal Ravinder4, Kimberly B Harding8, Gregory Reinhart9, Doris P Yimgang6, Kristen M Hurley10.
Abstract
BACKGROUND: Anemia is a global public health problem that undermines childhood development. India provides government-sponsored integrated nutrition/child development preschools.Entities:
Keywords: India; anemia; child development; iron deficiency; multiple micronutrient powders; preschool
Mesh:
Substances:
Year: 2021 PMID: 33880548 PMCID: PMC8245888 DOI: 10.1093/jn/nxab066
Source DB: PubMed Journal: J Nutr ISSN: 0022-3166 Impact factor: 4.687
FIGURE 1CONSORT diagram—preschool phase. CONSORT, Consolidated Standards of Reporting Trials.
Baseline household, mother, and child characteristics by intervention group and preschool quality among children attending 22 preschools (n = 321)[1]
| MNP preschools | Placebo preschools | |||||
|---|---|---|---|---|---|---|
| High quality ( | Low quality ( | High quality ( | Low quality ( | MNP group difference[ | Quality group difference[ | |
| Household | ||||||
| Food insecurity, | 13 (14.0) | 14 (18.2) | 13 (20.0) | 7 (8.1) | 0.40 | 0.21 |
| Household assets, | 3.0 ± 0.2 | 3.1 ± 0.2 | 3.2 ± 0.2 | 2.9 ± 0.2 | 0.83 | 0.71 |
| HOME Inventory score | 25.5 ± 1.2 | 23.4 ± 1.3 | 26.3 ± 1.4 | 26.1 ± 1.3 | 0.20 | 0.39 |
| Mother | ||||||
| Age, y | 24.6 ± 0.3 | 25.2 ± 0.4 | 25.6 ± 0.4 | 24.7 ± 0.4 | 0.51 | 0.71 |
| Married, | 91 (97.8) | 76 (98.7) | 65 (100) | 86 (100) | 0.10 | 0.55 |
| BMI, kg/m2 | 20.0 ± 4.1 | 20.4 ± 4.6 | 20.6 ± 4.9 | 19.5 ± 3.1 | 0.66 | 0.51 |
| No schooling, | 29 (31.2) | 20 (26.0) | 15 (23.1) | 24 (28.2) | 0.54 | 0.98 |
| Child | ||||||
| Age, mo | 37.4 ± 5.1 | 37.5 ± 5.6 | 36.9 ± 4.0 | 36.3 ± 4.6 | 0.38 | 0.67 |
| Male sex, | 40 (43.0) | 39 (50.6) | 34 (52.3) | 42 (48.8) | 0.44 | 0.76 |
| WAZ | –1.9 ± 0.1 | –1.9 ± 0.1 | –1.9 ± 0.1 | –2.1 ± 0.1 | 0.37 | 0.20 |
| HAZ | –1.6 ± 0.1 | –1.8 ± 0.1 | −1.9 ± 0.1 | –1.9 ± 0.1 | 0.25 | 0.52 |
| BAZ | –1.2 ± 0.1 | –1.1 ± 0.1 | –1.0 ± 0.1 | –1.3 ± 0.1 | 0.91 | 0.23 |
| MUACZ | –1.2 ± 0.1 | –1.3 ± 0.1 | –1.2 ± 0.1 | –1.4 ± 0.1 | 0.93 | 0.31 |
| Stunted, | 36 (38.7) | 31 (40.8) | 28 (43.1) | 35 (40.7) | 0.73 | 0.98 |
| Underweight, | 39 (41.9) | 32 (42.1) | 31 (47.7) | 46 (53.5) | 0.11 | 0.58 |
| Wasted, | 19 (20.4) | 15 (19.7) | 11 (16.9) | 19 (22.1) | 0.95 | 0.65 |
Characteristic values are means ± SDs unless otherwise indicated. BAZ, BMI-for-age z score; HAZ, height-for-age z score; HOME, Home Observation for the Measurement of the Environment Inventory; MNP, multiple micronutrient powder; MUACZ, midupper arm circumference z score; WAZ, weight-for-age z score.
Statistical difference (P value) in characteristic between MNP and placebo group.
Statistical difference (P value) in characteristic between high and low preschool quality.
Measures of child development by preschool quality, in preschoolers administered MNP or placebo from baseline to endline (8 mo)[1]
| Time effects ( | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High-quality preschools | Effect size | Low-quality preschools | Effect size | Baseline preschool | Endline × | Endline × | Endline × MNP × | |||||||
| ∆[ |
| MNP | Placebo |
| (95% CI) | MNP | Placebo |
| (95% CI)[ | quality | MNP | quality | quality | |
| Expressive language score[ | BL | 321 | 41.6 ± 1.2 | 40.1 ± 1.4 | 0.34 | 38.2 ± 1.3 | 36.8 ± 1.3 | 0.34 | 0.02 | |||||
| EL | 293 | 40.5 ± 1.4 | 40.8 ± 1.6 | 0.89 | 40.2 ± 1.5 | 34.4 ± 1.4 | 0.003 | 0.02 | 0.11 | 0.01 | ||||
| ∆ | –1.0 ± 1.2 | 0.6 ± 1.5 | 0.36 | –0.2 (–0.6, 0.2) | 2.0 ± 1.4 | –2.3 ± 1.2 | 0.02 | 0.4 (0.1, 0.8) | ||||||
| Receptive language score[ | BL | 321 | 43.7 ± 0.8 | 43.0 ± 0.9 | 0.52 | 41.5 ± 0.9 | 40.8 ± 0.8 | 0.52 | 0.03 | |||||
| EL | 293 | 37.4 ± 0.9 | 37.0 ± 1.1 | 0.74 | 34.5 ± 1.0 | 35.3 ± 0.9 | 0.57 | 0.28 | 0.70 | 0.49 | ||||
| ∆ | –6.2 ± 0.9*** | –6.1 ± 1.0*** | 0.88 | 0.0 (−0.4, 0.4) | –6.9 ± 1.0*** | –5.5 ± 0.9*** | 0.28 | –0.2 (–0.5, 0.2) | ||||||
| Fine motor score[ | BL | 321 | 46.5 ± 1.4 | 46.5 ± 1.5 | 1.00 | 44.1 ± 1.5 | 44.1 ± 1.4 | 1.00 | 0.15 | |||||
| EL | 293 | 47.8 ± 1.5 | 46.5 ± 1.5 | 0.81 | 44.5 ± 1.6 | 44.2 ± 1.5 | 0.90 | 0.89 | 0.73 | 0.92 | ||||
| ∆ | 47.3 ± 1.7 | 0.79 | 0.0 (–0.3, 0.3) | 0.4 ± 1.4 | 0.1 ± 1.3 | 0.89 | 0.0 (–0.3, 0.3) | |||||||
| Visual reception score[ | BL | 321 | 43.9 ± 1.2 | 42.3 ± 1.4 | 0.27 | 42.3 ± 1.3 | 40.6 ± 1.3 | 0.27 | 0.27 | |||||
| EL | 293 | 42.7 ± 1.3 | 42.7 ± 1.6 | 1.00 | 41.0 ± 1.5 | 40.0 ± 1.4 | 0.57 | 0.74 | 0.52 | 0.64 | ||||
| ∆ | –1.2 ± 1.1 | 0.5 ± 1.4 | 0.34 | –0.2 (–0.5, 0.2) | –1.2 ± 1.3 | –0.7 ± 1.2 | 0.74 | –0.1 (–0.4, 0.3) | ||||||
| Inhibitory control score[ | BL | 319 | 2.8 ± 0.4 | 2.3 ± 0.4 | 0.36 | 2.6 ± 0.4 | 2.2 ± 0.4 | 0.36 | 0.73 | |||||
| EL | 293 | 4.3 ± 0.4 | 5.0 ± 0.5 | 0.26 | 4.4 ± 0.5 | 3.0 ± 0.4 | 0.02 | 0.07 | 0.001 | 0.004 | ||||
| ∆ | 1.5 ± 0.4*** | 2.7 ± 0.4*** | 0.04 | –0.3 (–0.7, 0.0) | 1.8 ± 0.4*** | 0.8 ± 0.4* | 0.07 | 0.2 (–0.1, 0.6) | ||||||
| Social–emotional development score[ | BL | 321 | 24.7 ± 0.4 | 24.1 ± 0.4 | 0.19 | 23.8 ± 0.4 | 23.2 ± 0.4 | 0.19 | 0.07 | |||||
| EL | 293 | 22.8 ± 0.5 | 23.3 ± 0.6 | 0.47 | 23.3 ± 0.5 | 21.9 ± 0.5 | 0.03 | 0.26 | 0.48 | 0.04 | ||||
| ∆ | –1.9 ± 0.5** | –0.8 ± 0.6 | 0.13 | –0.3 (–0.8, 0.1) | –0.5 ± 0.6 | –1.3 ± 0.5* | 0.26 | 0.2 (–0.2, 0.6) | ||||||
Values are means ± SEs unless otherwise indicated. *P < 0.05, **P < 0.001, ***P < 0.0001. BL, baseline; EL, endline; MNP, multiple micronutrient powder.
Within-intervention group change from baseline.
P value for MNP compared with placebo difference in baseline mean, endline mean, and change from baseline.
Cohen's d for the difference in change scores from baseline to endline comparing MNP with placebo. Conventions: small = 0.2, medium = 0.5, large = 0.8 (38).
Mean T scores ± SEs, age-standardized.
Raw score, adjusted for mean-centered age.
FIGURE 2Change in expressive language score in preschoolers from high-quality (A) and low-quality (B) preschools administered MNP or placebo from baseline to endline (8 mo). In A, MNP = 93 and 84 and placebo = 65 and 59 at baseline and endline, respectively. In B, MNP = 77 and 67 and placebo = 86 and 83 at baseline and endline, respectively. Lines are adjusted means of expressive language score from linear mixed-effect regression models. MNP, multiple micronutrient powder.
MNP compared with placebo mean differences on measures of hemoglobin, biomarkers of micronutrient status, and CRP in preschoolers from baseline to endline[1]
| MNP vs. placebo[ | Time effect ( | ||||||
|---|---|---|---|---|---|---|---|
|
| MNP | Placebo |
| Effect size (95% CI)[ | |||
| Hemoglobin, g/dL | BL | 316 | 10.9 ± 0.1 | 10.9 ± 0.1 | 0.85 | ||
| EL | 289 | 12.1 ± 0.1 | 11.2 ± 0.1 | <0.0001 | <0.0001 | ||
| ∆[ | 1.2 ± 0.1**** | 0.3 ± 0.1** | <0.0001 | 0.6 (0.4, 0.8) | |||
| Ferritin, μg/L | BL | 314 | 19.5 ± 1.3 | 15.8 ± 1.4 | 0.06 | ||
| EL | 288 | 24.6 ± 1.4 | 14.3 ± 1.5 | <0.0001 | 0.0004 | ||
| ∆ | 5.1 ± 1.3*** | –1.5 ± 1.3 | 0.0004 | 0.3 (0.1, 0.6) | |||
| sTfR, mg/L | BL | 299 | 3.3 ± 0.1 | 3.4 ± 0.1 | 0.38 | ||
| EL | 287 | 2.3 ± 0.1 | 3.3 ± 0.1 | <0.0001 | <0.0001 | ||
| ∆ | –1.0 ± 0.1**** | –0.1 ± 0.1* | <0.0001 | 0.6 (0.4, 0.7) | |||
| sTfR/log ferritin index, mg/μg | BL | 299 | 3.4 ± 0.2 | 3.5 ± 0.2 | 0.66 | ||
| EL | 287 | 1.8 ± 0.2 | 3.3 ± 0.2 | <0.0001 | <0.0001 | ||
| ∆ | –1.6 ± 0.1**** | –0.2 ± 0.1 | <0.0001 | 0.7 (0.5, 0.9) | |||
| Folate, nmol/L | BL | 314 | 5.4 ± 0.2 | 5.1 ± 0.2 | 0.19 | ||
| EL | 287 | 7.0 ± 0.2 | 6.1 ± 0.2 | 0.002 | 0.09 | ||
| ∆ | 1.6 ± 0.2**** | 1.0 ± 0.2**** | 0.09 | 0.3 (0.0, 0.5) | |||
| Vitamin B-12, pmol/L | BL | 314 | 448.6 ± 18.8 | 411.1 ± 19.8 | 0.17 | ||
| EL | 287 | 492.6 ± 19.8 | 443.1 ± 20.3 | 0.08 | 0.72 | ||
| ∆ | 44.0 ± 22.9 | 32.0 ± 23.6 | 0.72 | 0.0 (–0.4, 0.2) | |||
| Zinc, μmol/L | BL | 307 | 14.3 ± 0.6 | 13.4 ± 0.7 | 0.35 | ||
| EL | 289 | 14.3 ± 0.6 | 13.9 ± 0.7 | 0.68 | 0.35 | ||
| ∆ | 0.0 ± 0.3 | 0.5 ± 0.4 | 0.35 | –0.1 (–0.4, 0.2) | |||
| CRP, mg/L | BL | 303 | 1.9 ± 0.2 | 1.8 ± 0.2 | 0.83 | ||
| EL | 287 | 1.2 ± 0.2 | 1.1 ± 0.2 | 0.88 | 0.96 | ||
| ∆ | –0.7 ± 0.3* | –0.7 ± 0.3* | 0.96 | 0.0 (–0.3, 0.3) | |||
Values are means ± SEs unless otherwise indicated. Linear mixed-effects regression models with random preschool and subject intercepts fitted for each outcome. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. BL, baseline; CRP, C-reactive protein; EL, endline; MNP, multiple micronutrient powder; sTfR, soluble transferrin receptor.
No evidence of differing MNP compared with placebo effects on biochemical values by preschool quality; pooled analysis results presented.
Within-intervention group change from baseline.
P value for MNP compared with placebo difference in baseline mean, endline mean, and change from baseline.
Cohen's d for the difference in change scores from baseline to endline comparing MNP with placebo. Conventions: small = 0.2, medium = 0.5, large = 0.8 (38).
FIGURE 3Prevalence of anemia, ferritin deficiency (<12 μg/L), sTfR deficiency (>2.5 mg/L), STfR/log ferritin deficiency (≥1.9 mg/μg), and iron deficiency (low ferritin and/or high sTfR regardless of anemia status) at baseline and endline in preschoolers who received MNP or placebo. Prevalence of anemia (means ± SEs): MNP = 46.7 ± 7.6% (n = 167) and 10.1 ± 4.9% (n = 148), placebo = 49.0 ± 8.0% (n = 149) and 35.5 ± 7.9% (n = 141) at baseline and endline, respectively. Prevalence of ferritin deficiency (means ± SEs): MNP = 43.1 ± 7.5% (n = 166) and 9.5 ± 4.8% (n = 147), placebo = 47.6 ± 8.1% (n = 148) and 50.3 ± 8.3% (n = 141) at baseline and endline, respectively. Prevalence of sTfR deficiency (means ± SEs): MNP = 67.3 ± 7.4% (n = 153) and 24.0 ± 6.9% (n = 147), placebo = 66.4 ± 7.7% (n = 146) and 65.3 ± 7.9% (n = 141) at baseline and endline, respectively. Prevalence of sTfR/log ferritin deficiency (means ± SEs): MNP = 62.9 ± 7.1% (n = 153) and 25.7 ± 7.4% (n = 147), placebo = 71.8 ± 7.2% (n = 146) and 73.8 ± 7.3% (n = 141) at baseline and endline, respectively. Prevalence of iron deficiency (means ± SEs): MNP = 73.0 ± 6.8% (n = 166) and 32.4 ± 7.5% (n = 148), placebo = 77.8 ± 6.7% (n = 148) and 76.6 ± 7.0% (n = 141) at baseline and endline, respectively. Chi-square test was used to compare prevalence at baseline and endline; statistically significant P values are shown. MNP, multiple micronutrient powder; sTfR, soluble transferrin receptor.
FIGURE 4Proportion of preschoolers without anemia (Hb >110 g/L), with mild anemia (Hb = 100–110 g/L), with moderate anemia (Hb = 70–100 g/L), and with severe anemia (Hb <70 g/L) in MNP and placebo groups at baseline and endline separately. At baseline (means ± SEs), 53.3 ± 3.9% (n = 167) and 51.0 ± 4.1% (n = 148) did not have anemia, 21.6 ± 3.2% (n = 167) and 26.2 ± 3.6% (n = 148) had mild anemia, and 25.1 ± 3.3% (n = 167) and 22.8 ± 3.4% (n = 148) had moderate anemia in MNP and placebo, respectively; there were no preschoolers with severe anemia. At endline, 89.9 ± 4.8% (n = 148) and 64.5 ± 7.9% (n = 141) did not have anemia, 8.1 ± 4.4% (n = 148) and 15.6 ± 6.0% (n = 141) had mild anemia, 2.0 ± 2.3% (n = 148) and 19.2 ± 6.5% (n = 141) had moderate anemia, and 0 ± 0% (n = 148) and 0.7 ± 1.4% (n = 141) had severe anemia in MNP and placebo, respectively. Fisher's exact test was used to compare anemia severity in MNP and placebo groups at baseline and endline separately. Significant P value at endline is shown. Hb, hemoglobin; MNP, multiple micronutrient powder.
MNP compared with placebo mean differences on measures of standardized anthropometric growth in preschoolers from baseline to endline[1]
| MNP vs. placebo[ | |||||||
|---|---|---|---|---|---|---|---|
|
| MNP | Placebo |
| Effect size (95% CI)[ | Endline × MNP[ | ||
| HAZ | BL | 321 | –1.7 ± 0.1 | –1.9 ± 0.1 | 0.27 | ||
| EL | 293 | –1.5 ± 0.1 | –1.7 ± 0.1 | 0.15 | 0.22 | ||
| ∆[ | 0.2 ± 0.02**** | 0.1 ± 0.02**** | 0.22 | 0.14 (–0.02, 0.3) | |||
| WAZ | BL | 321 | –1.9 ± 0.1 | –2.0 ± 0.1 | 0.34 | ||
| EL | 293 | –1.7 ± 0.1 | –1.9 ± 0.1 | 0.13 | 0.13 | ||
| ∆ | 0.2 ± 0.03**** | 0.1 ± 0.03*** | 0.13 | 0.12 (–0.04, 0.3) | |||
| BAZ | BL | 321 | –1.2 ± 0.1 | –1.1 ± 0.1 | 0.96 | ||
| EL | 293 | –1.1 ± 0.1 | –1.1 ± 0.1 | 0.72 | 0.42 | ||
| ∆ | 0.1 ± 0.04 | 0.02 ± 0.04 | 0.42 | 0.02 (–0.1, 0.2) | |||
| MUACZ | BL | 321 | –1.2 ± 0.1 | –1.3 ± 0.1 | 0.84 | ||
| EL | 293 | –1.0 ± 0.1 | –1.1 ± 0.1 | 0.65 | 0.62 | ||
| ∆ | 0.2 ± 0.0**** | 0.2 ± 0.0**** | 0.62 | 0.03 (–0.1, 0.2) | |||
Values are means ± SEs unless otherwise indicated. Linear mixed-effects regression models with random preschool and subject intercepts fitted for each outcome. ***P < 0.001, ****P < 0.0001. BAZ, BMI-for-age z score; BL, baseline; EL, endline; HAZ, height-for-age z score; MNP, multiple micronutrient powder; MUACZ, midupper arm circumference z score; WAZ, weight-for-age z score.
No evidence of differing MNP compared with placebo effects on biochemical values by preschool quality; pooled analysis results presented.
Within-intervention group change from baseline.
P value for MNP compared with placebo difference in baseline mean, endline mean, and change from baseline.
Cohen's d for the difference in change scores from baseline to endline comparing MNP with placebo. Conventions: small = 0.2, medium = 0.5, large = 0.8 (38).
Time/MNP interaction effect on standardized measures of anthropometric growth.
Effects of MNP compared with placebo fortification on morbidity measures in preschoolers over time[1,2]
| Time ( | OR (95% CI) |
| |
|---|---|---|---|
| Acute respiratory infection, episodes | MNP | 1.58 (0.7, 3.6) | 0.27 |
| Placebo | 1.15 (1.01, 1.3) | 0.03 | |
| MNP vs. placebo | 1.38 (0.7, 2.9) | 0.39 | |
| Time × MNP | — | 0.94[ | |
| Diarrhea, incidents | MNP | 0.82 (0.4, 1.7) | 0.61 |
| Placebo | 0.78 (0.7, 0.9) | 0.003 | |
| MNP vs. placebo | 1.05 (0.5, 2.1) | 0.89 | |
| Time × MNP | — | 0.07[ |
Generalized linear mixed-effects regression models with random preschool and subject intercepts fitted for each outcome; Time in months is treated as continuous. MNP, multiple micronutrient powder.
Recall by month over 15 d.
P value for OR ≠ 1.00.
P value for time–MNP interaction effect.